Please login to the form below

Not currently logged in
Email:
Password:

Oncotype DX

This page shows the latest Oncotype DX news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment

Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment

The diagnosis relies on a genetic test that analyses the danger of a tumour; in the trial Genomic Health's Oncotype Dx was used, although there are competing products.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...